AGC Biologics

AGC Biologics AGC Biologics has successfully manufactured more than 200 biological projects, from pre-clinical studies through commercial approvals.

We offer multiple cGMP manufacturing lines at a variety of scales for mammalian cell culture and microbial fermentation

06/01/2026

๐Ÿ—“๏ธ June is ๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐จ๐ง๐ญ๐ก, a time to celebrate the advancement of immune-based cancer treatments that are reshaping cancer care.

AGC Biologics is proud to support our immunotherapy development partners by providing regulatory guidance and reliable, scalable cGMP manufacturing services for complex immunotherapies, enabling patients around the globe to access these critical treatments.

Know anyone working in immunotherapy development? Say thank you by tagging them in the comments. ๐Ÿ‘‡

โ‡” โ€œScale-outโ€ manufacturing is a strategy every biologic developer should consider for its ability to accelerate timelin...
05/28/2026

โ‡” โ€œScale-outโ€ manufacturing is a strategy every biologic developer should consider for its ability to accelerate timelines, lower costs, and derisk demand uncertainty in todayโ€™s market.

Anders Cai Holm Hansen, Principal Scientist Customer Solution Design at AGC Biologics, recently sat down for an interview with BioSpaceยฎ to discuss our single-use technology (SUT) that supports a scale-out manufacturing approach, and its ability to support high-yield perfusion processes for complex molecule manufacturing.

Read the article here: https://hubs.ly/Q04hHhJz0

05/27/2026

๐Ÿ“ฃ Cell and gene therapy webinar available on demand!

๐€ ๐Ÿ‘-๐’๐ญ๐š๐ ๐ž ๐†๐ฎ๐ข๐๐ž ๐ญ๐จ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ข๐ฏ๐ž ๐‚๐ž๐ฅ๐ฅ & ๐†๐ž๐ง๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐๐ซ๐จ๐œ๐ž๐ฌ๐ฌ ๐•๐š๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง

Watch as Monika Pema, Senior Manager MSAT, and Francesca Rossetti, Analytical Method Development Director, AGC Biologics Cell & Gene Center of Excellence in Milan, walk through best practices for advancing CGT therapies from early development to commercialization. See the strategy used by AGC Biologics to gain FDA and EMA approval of Orchard Therapeuticsโ€™ Lenmedlyโ„ข, a hematopoietic stem cell therapy for treatment of metachromatic leukodystrophy (MLD).

๐ŸŽฅ Watch now: https://hubs.ly/Q04hGPgp0

Thereโ€™s an undeniable shift toward regionalizing production and supply chain in biopharma manufacturing. A new article i...
05/26/2026

Thereโ€™s an undeniable shift toward regionalizing production and supply chain in biopharma manufacturing. A new article in Pharma Boardroom explains how industry leaders, like AGC, are rising to meet this growing demand.

As our CEO, Alberto Santagostino, explains: โ€œ๐˜”๐˜ฐ๐˜ณ๐˜ฆ ๐˜ค๐˜ถ๐˜ด๐˜ต๐˜ฐ๐˜ฎ๐˜ฆ๐˜ณ๐˜ด ๐˜ข๐˜ณ๐˜ฆ ๐˜ฆ๐˜น๐˜ฑ๐˜ญ๐˜ช๐˜ค๐˜ช๐˜ต๐˜ญ๐˜บ ๐˜ณ๐˜ฆ๐˜ฒ๐˜ถ๐˜ฆ๐˜ด๐˜ต๐˜ช๐˜ฏ๐˜จ ๐˜ฅ๐˜ถ๐˜ข๐˜ญ-๐˜ณ๐˜ฆ๐˜จ๐˜ช๐˜ฐ๐˜ฏ ๐˜ด๐˜ถ๐˜ฑ๐˜ฑ๐˜ญ๐˜บ ๐˜ด๐˜ต๐˜ณ๐˜ข๐˜ต๐˜ฆ๐˜จ๐˜ช๐˜ฆ๐˜ด ๐˜ข๐˜ฏ๐˜ฅ, ๐˜ง๐˜ฐ๐˜ณ ๐˜ฏ๐˜ฐ๐˜ฏ-๐˜œ๐˜š ๐˜ฅ๐˜ฆ๐˜ฎ๐˜ข๐˜ฏ๐˜ฅ, ๐˜ต๐˜ฉ๐˜ฆ๐˜ณ๐˜ฆ ๐˜ช๐˜ด ๐˜ฐ๐˜ง๐˜ต๐˜ฆ๐˜ฏ ๐˜ข ๐˜ค๐˜ญ๐˜ฆ๐˜ข๐˜ณ ๐˜ฆ๐˜น๐˜ฑ๐˜ฆ๐˜ค๐˜ต๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ต๐˜ฉ๐˜ข๐˜ต ๐˜ด๐˜ถ๐˜ฑ๐˜ฑ๐˜ญ๐˜บ ๐˜ด๐˜ฉ๐˜ฐ๐˜ถ๐˜ญ๐˜ฅ ๐˜ข๐˜ญ๐˜ด๐˜ฐ ๐˜ฃ๐˜ฆ ๐˜ฏ๐˜ฐ๐˜ฏ-๐˜œ๐˜š ๐˜ฃ๐˜ข๐˜ด๐˜ฆ๐˜ฅ. ๐˜š๐˜ฐ ๐˜ณ๐˜ข๐˜ต๐˜ฉ๐˜ฆ๐˜ณ ๐˜ต๐˜ฉ๐˜ข๐˜ฏ ๐˜ข ๐˜ด๐˜ช๐˜ฎ๐˜ฑ๐˜ญ๐˜ฆ ๐˜ด๐˜ฉ๐˜ช๐˜ง๐˜ต ๐˜ช๐˜ฏ ๐˜ฐ๐˜ฏ๐˜ฆ ๐˜ฅ๐˜ช๐˜ณ๐˜ฆ๐˜ค๐˜ต๐˜ช๐˜ฐ๐˜ฏ, ๐˜ธ๐˜ฆ ๐˜ด๐˜ฆ๐˜ฆ ๐˜ข ๐˜จ๐˜ฆ๐˜ฐ๐˜จ๐˜ณ๐˜ข๐˜ฑ๐˜ฉ๐˜ช๐˜ค๐˜ข๐˜ญ ๐˜ด๐˜ฑ๐˜ญ๐˜ช๐˜ฏ๐˜ต๐˜ฆ๐˜ณ๐˜ช๐˜ฏ๐˜จ ๐˜ข๐˜ญ๐˜ฐ๐˜ฏ๐˜จ ๐˜ณ๐˜ฆ๐˜จ๐˜ช๐˜ฐ๐˜ฏ๐˜ข๐˜ญ ๐˜ญ๐˜ช๐˜ฏ๐˜ฆ๐˜ด.โ€

๐Ÿ‘‰๐ŸปRead the full article for more insights from our CEO: https://hubs.ly/Q04hHl5P0

Global manufacturing flexibility continues to be a growing priority for biopharma developers.  We've been selected by Te...
05/26/2026

Global manufacturing flexibility continues to be a growing priority for biopharma developers.

We've been selected by Teikoku Seiyaku Co., Ltd. to provide microbial development and GMP manufacturing services for KTP-001, an rhMMP-7 therapy being developed for lumbar disc herniation.

โ€œPartnering with AGC Biologics was a clear choice. Their team has a proven track record in microbial manufacturing, and their global presence gives us the flexibility and security we need.โ€ โ€” Dr. Hiroyuki Kubo, Director and Executive Officer at Teikoku Seiyaku

The project will leverage our microbial network across Germany and Japan to support development and clinical manufacturing.

Learn more: https://hubs.ly/Q04hKjb_0

In recognition of ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ๐ฌ ๐ƒ๐š๐ฒ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”, we celebrate the researchers, developers, manufacturers, and clinical care t...
05/20/2026

In recognition of ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ๐ฌ ๐ƒ๐š๐ฒ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”, we celebrate the researchers, developers, manufacturers, and clinical care teams driving progress in medicine. We also thank the patients who participate in clinical trials and contribute to advancing future therapies.

At AGC Biologics, we are proud to take part in this mission, having manufactured ๐ก๐ข๐ ๐ก ๐ช๐ฎ๐š๐ฅ๐ข๐ญ๐ฒ ๐๐ซ๐ฎ๐  ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ ๐Ÿ๐จ๐ซ ๐ก๐ฎ๐ง๐๐ซ๐ž๐๐ฌ ๐จ๐Ÿ ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐ญ๐ซ๐ข๐š๐ฅ๐ฌ.

๐Ÿ‘ Tag your colleagues in the comments as a way to thank them for all they do to support this critical work!

05/19/2026

๐Ÿ—“๏ธ THIS WEEK: Learn how our global network can support your biologics development and manufacturing needs, May 20-22, at INTERPHEX Week Tokyo at Makuhari Messe in Chiba City, Japan!

Connect with our team in ๐›๐จ๐จ๐ญ๐ก #๐Ÿ๐Ÿ“-๐Ÿ’๐ŸŽ or schedule a meeting to explore solutions that can help you advance your project to the next phase: https://hubs.ly/Q04hd8KR0

Connect with us THIS WEEK at CDMO Live Europe, May 19-21 in Rotterdam, Netherlands! ๐Ÿค Stop by ๐›๐จ๐จ๐ญ๐ก ๐’-๐Ÿ’๐ŸŽ, or schedule a ...
05/19/2026

Connect with us THIS WEEK at CDMO Live Europe, May 19-21 in Rotterdam, Netherlands!

๐Ÿค Stop by ๐›๐จ๐จ๐ญ๐ก ๐’-๐Ÿ’๐ŸŽ, or schedule a meeting with our team to discuss your biologics development and manufacturing needs:

https://hubs.ly/Q04gPDsF0

We look forward to seeing you!

โฐ Join us tomorrow, May 19th at 11:00 AM ET for ๐—ข๐˜‚๐˜๐˜€๐—ผ๐˜‚๐—ฟ๐—ฐ๐—ฒ๐—ฑ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ ๐—–๐—ฎ๐—ฝ๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐—ถ๐—ฒ๐˜€ ๐—จ๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ ๐— ๐—ฎ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ: ๐— ๐—ฎ๐—บ๐—บ๐—ฎ๐—น๐—ถ๐—ฎ๐—ป ๐—–๐—ฒ๐—น๐—น ๐—–๐˜‚๐—น๐˜๐˜‚๐—ฟ๐—ฒ.D...
05/18/2026

โฐ Join us tomorrow, May 19th at 11:00 AM ET for ๐—ข๐˜‚๐˜๐˜€๐—ผ๐˜‚๐—ฟ๐—ฐ๐—ฒ๐—ฑ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ ๐—–๐—ฎ๐—ฝ๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐—ถ๐—ฒ๐˜€ ๐—จ๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ ๐— ๐—ฎ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ: ๐— ๐—ฎ๐—บ๐—บ๐—ฎ๐—น๐—ถ๐—ฎ๐—ป ๐—–๐—ฒ๐—น๐—น ๐—–๐˜‚๐—น๐˜๐˜‚๐—ฟ๐—ฒ.

Discover how AGC Biologics can support complex molecule development at any stage with our expertise, state-of-the-art platforms and facilities, cGMP processes, and ability to scale with your needsโ€”helping you reach the market faster.

โžก๏ธ Register NOW: https://hubs.ly/Q04gPRH40

05/14/2026

๐Ÿ”† Service Spotlight: Perfusion Manufacturing

In this video, Pascal Leonov, Senior Scientist at AGC Biologics Copenhagen, explains how our team successfully combined fed batch and perfusion techniques to optimize cell culture conditions and maximize yields of a sensitive protein for use in clinical trials.

Watch innovation in action โฌ‡๏ธ

Address

21511 23rd Drive SE
Bothell, WA
98021

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+14254851900

Alerts

Be the first to know and let us send you an email when AGC Biologics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to AGC Biologics:

Share